Xiuyu Cui

Response to auxin changes during maturation-related loss of adventitious rooting competence in loblolly pine (Pinus taeda) stem cuttings.

A comparison of murine T-cell-depleted adult bone marrow and full-term fetal blood cells in hematopoietic engraftment and immune reconstitution.

Mechanisms of tolerance induced by PG490-88 in a bone marrow transplantation model.

Addition of a second, different allogeneic graft accelerates white cell and platelet engraftment after T-cell-depleted bone marrow transplantation.

Prevention of graft-versus-host disease while preserving graft-versus-leukemia effect after selective depletion of host-reactive T cells by photodynamic cell purging process.

Growth hormone accelerates immune recovery following allogeneic T-cell-depleted bone marrow transplantation in mice.

Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease.

Hematopoietic stem cell dose correlates with the speed of immune reconstitution after stem cell transplantation.

Changes in cPKC isoform-specific membrane translocation and protein expression in the brain of hypoxic preconditioned mice.

Vascular endothelial cells produce soluble factors that mediate the recovery of human hematopoietic stem cells after radiation injury.

Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells.

Inability of memory T cells to induce graft-versus-host disease is a result of an abortive alloresponse.

Frequency-dependent ERK phosphorylation in spinal neurons by electric stimulation of the sciatic nerve and the role in electrophysiological activity.

Phospholipase C and protein kinase A mediate bradykinin sensitization of TRPA1: a molecular mechanism of inflammatory pain.

Selective modification of antigen-specific T cells by RNA electroporation.

Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humans.

CD62L- memory T cells enhance T-cell regeneration after allogeneic stem cell transplantation by eliminating host resistance in mice.

Myeloablative temozolomide enhances CD8⁺ T-cell responses to vaccine and is required for efficacy against brain tumors in mice.